fluorouracil has been researched along with imiquimod in 156 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (0.64) | 18.2507 |
| 2000's | 34 (21.79) | 29.6817 |
| 2010's | 84 (53.85) | 24.3611 |
| 2020's | 37 (23.72) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Beutner, KR; Ferenczy, A | 1 |
| Pehoushek, J; Smith, KJ | 1 |
| Germain, M; Skelton, H; Smith, KJ | 1 |
| Caglar, S; Crespo, J; Saini, R; Tutrone, WD; Weinberg, JM | 1 |
| Schmook, T; Stockfleth, E | 1 |
| Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
| Alam, M; Goldberg, LH; Silapunt, S | 1 |
| Bernard, HU | 1 |
| Kelly, AP | 1 |
| Fein, H; McGillis, ST | 1 |
| Jorizzo, JL | 1 |
| Smolinski, KN; Yan, AC | 1 |
| Downs, AM; Geraghty, JM; Jones, C | 1 |
| Berman, B; Ramirez, CC; Villa, AM | 1 |
| Davey, V; Gupta, AK; Mcphail, H | 1 |
| Berman, B; Bienstock, L; Kuritzky, L; Mayeaux, EJ; Tyring, SK | 1 |
| Edelstein, L; Rhew, DC; Ye, JN; Yip, F | 1 |
| Dissemond, J; Grabbe, S | 1 |
| Mings, SM; Ondo, AL; Pestak, RM; Shanler, SD | 1 |
| Cox, NH; Eedy, DJ; Morton, CA | 1 |
| Chia, AL; Lim, A; Moreno, G; Shumack, S | 1 |
| Khachemoune, A; Prager, R | 1 |
| Tanghetti, E; Werschler, P | 1 |
| Price, NM | 1 |
| Bedwell, SA; Downs, MR; McIntyre, WJ | 1 |
| Krawtchenko, N; Mann, I; Roewert-Huber, J; Sterry, W; Stockfleth, E; Ulrich, M | 1 |
| Gold, MH | 1 |
| Mitropoulos, P; Norman, R | 1 |
| Weinberg, JM | 1 |
| Stockfleth, E | 1 |
| Ulrich, C | 1 |
| Downs, A; Muston, D; Rives, V | 1 |
| Jacobs, AA; McClung, A; Modi, G; Orengo, IF; Rosen, T | 1 |
| Bernhard, JD; Bordeaux, JS; Love, WE | 1 |
| Dinotta, F; Lacarrubba, F; Massimino, D; Micali, G; Nasca, MR | 1 |
| Muhn, C; Rosen, N; Shoimer, I | 1 |
| Adam, F; Fenske, NA; Spencer, J | 1 |
| Braga, JC; Busam, K; Dusza, SW; Gill, M; Halpern, AC; Marghoob, AA; Scope, A; Terushkin, V | 1 |
| Bruckner-Tuderman, L; Burger, B; Has, C; Itin, P; Kohlhase, J; Volz, A | 1 |
| Goldenberg, G; Skupsky, H; Skupsky, J | 1 |
| Doherty, SD; Rosen, T; Shah, AY | 1 |
| Aguayo-Leiva, IR; Jaén-Olasolo, P; Ríos-Buceta, L | 1 |
| LeLeux, TM; Orengo, I; Rosen, T; Venkatarajan, S; Yang, D | 1 |
| Clark, AR; Huang, WW | 1 |
| Gaspari, AA; Grossberg, AL | 1 |
| Bergstrom, KG; Que, SK | 1 |
| Anolik, R; Brightman, L; Geronemus, R; Warycha, M | 1 |
| Desmedt, E; Florin, V; Mortier, L; Vercambre-Darras, S | 1 |
| Chen, CL; Desai, A; Desai, T; Kirby, W | 1 |
| Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ | 1 |
| Marghoob, AA; Tang, JY | 1 |
| Jadotte, YT; Schwartz, RA | 1 |
| Alnajjar, HM; Bolgeri, M; Lam, W; Perry, MJ; Rees, RW; Watkin, NA | 1 |
| Bakardzhiev, I; Kovachev, E | 1 |
| Cockerell, CJ; Kerner, JD; Miedler, JD; Mings, SM; Ondo, AL; Padilla, RS; Shanler, SD; Steiner, RL | 1 |
| Sullivan, TJ | 1 |
| Fox, PA | 1 |
| Firnhaber, JM | 1 |
| Gauglitz, GG; Pavicic, T | 1 |
| Esmann, S; Jemec, GB | 1 |
| Brassard, P; Ouhoummane, N; Rodier, C; Steben, M | 1 |
| Halpern, AC; Quigley, EA | 1 |
| Kreuter, A; Wieland, U | 1 |
| de Vries, HJ; Dijkgraaf, MG; Prins, JM; Richel, O; van Noesel, CJ | 1 |
| Gupta, AK; Paquet, M | 1 |
| Cockerell, CJ; Samrao, A | 1 |
| Dummer, R | 1 |
| Arits, AH; De Rooij, MJ; Essers, BA; Kelleners-Smeets, NW; Krekels, GA; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJ; Rijzewijk, JJ; Sommer, A; Spoorenberg, E; Steijlen, PM; van Geest, AJ; van Neer, PA; van Pelt, HP | 1 |
| Bath-Hextall, FJ; Leonardi-Bee, J; Matin, RN; Wilkinson, D | 1 |
| Chitwood, K; Cohen, G; Etzkorn, J | 1 |
| Calzavara Pinton, P; Catricalà, C; Neri, L; Pellacani, G; Peris, K; Peserico, A; Pimpinelli, N | 1 |
| Bayat, A; Ud-Din, S | 1 |
| Bejarano, PA; Berho, M; Boutros, M | 1 |
| Birnie, AJ; Eedy, DJ; Morton, CA | 1 |
| Jurado-Santa Cruz, F; Morales-Sánchez, MA; Olguin-García, MG; Peralta-Pedrero, ML | 1 |
| Arits, AH; Essers, BA; Kelleners-Smeets, NW; Mosterd, K; Nelemans, P; Spoorenberg, E | 1 |
| Arno, AI; Barret, JP; Gauglitz, GG; Jeschke, MG | 1 |
| Honda, M; Kato, T; Kawase, M; Mitsuishi, T; Yoshida, R | 1 |
| Gao, X; Geng, L; Shi, J; Wang, H; Xu, Y | 1 |
| Fargnoli, MC; Peris, K | 1 |
| Philipp-Dormston, WG | 1 |
| Knackstedt, TJ; Quitadamo, M | 1 |
| Arits, AH; Kelleners-Smeets, NW; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Kleef, L; van Marion, AM; Winnepenninckx, VJ | 1 |
| Cohen, JL; Friedman, A; Ruiz, ES | 1 |
| Alarcon, I; Sibbring, GC; Stockfleth, E | 1 |
| Isoherranen, K; Koskenmies, S; Overmark, M; Pitkänen, S; Saksela, O; Ylitalo, L | 1 |
| Alkemade, HA; Gerritsen, MJ; Groenewoud, H; Grutters, JP; Maessen-Visch, MB; Seubring, I; van de Kerkhof, PC; van der Wilt, GJ; van Doorn, R; van Rijsingen, MC | 1 |
| Erdmann, R; Jacobs, A; Nast, A; Rosumeck, S; Sporbeck, B; Werner, RN | 1 |
| Bay, C; Haedersdal, M; Lerche, CM; Togsverd-Bo, K | 1 |
| Enos, CW; Harvey, VM; Mantel, A; Trace, AP | 1 |
| Federman, DG; Wiznia, LE | 1 |
| Arits, AHMM; de Rooij, MJM; Essers, BAB; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM | 1 |
| Fabi, SG; Zaleski-Larsen, LA | 1 |
| Gilaberte, Y; González, S; Gracia-Cazaña, T | 1 |
| Lv, R; Sun, Q | 1 |
| Ariza, S; Espinosa, S; Naranjo, M | 1 |
| Arits, AH; Essers, BAB; Hendriks, MR; Kelleners-Smeets, NW; Mosterd, K | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Roozeboom, MH; Sommer, A; Steijlen, PM; van Pelt, HPA | 1 |
| Salido Vallejo, R | 1 |
| Dietert, JB; Hurst, EA; Singla, P | 1 |
| Asgari, MM; Chren, MM; Friedman, GD; Levandoski, KA; Neugebauer, R; Sokil, M; Zhu, Z | 1 |
| Shaw, FM; Weinstock, MA | 1 |
| Arits, AHMM; Jansen, MHE; Kelleners-Smeets, NWJ; Koekelkoren, FHJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH | 1 |
| Aberbigbe, O; Etzkorn, JR; Neal, DE; Smith, RJ | 1 |
| da Motta, VRV; de Oliveira, ECV; Galadari, H; Ilha, CSO; Leonardi, GR; Magalhães, RF; Pantoja, PC | 1 |
| Calzavara-Pinton, P; Hamon, P; Tanova, N | 1 |
| Asgari, MM; Chren, MM; Friedman, GD; Neugebauer, R; Sokil, M; Su, KA; Zhu, Z | 1 |
| Arits, AHMM; Hamid, MA; Jansen, MHE; Kelleners-Smeets, NWJ; Mosterd, K; Nelemans, PJ; Roozeboom, MH; van Delft, LCJ | 1 |
| Caruntu, C; Constantin, MM; Draghici, CC; Lisievici, CV; Lupu, M; Popa, AV; Sebe, TI; Solomon, I; Vajaitu, C; Voiculescu, VM | 1 |
| Chen, L; Cornelius, LA; Demehri, S; Faulkner-Jones, BE; Khalifian, S; Molina, GE; Mull, JL; Ngo, KH; Rosman, IS; Wu, PA | 1 |
| Arits, AHMM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Kouloubis, N; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF; Steijlen, PM; van Pelt, HPA | 1 |
| Council, ML; Nemer, KM | 1 |
| Herms, F | 1 |
| Dréno, B; Paugam, C | 1 |
| Kircik, LH | 1 |
| Cornacchia, L; Lai, M; Longo, C; Pampena, R; Pellacani, G; Peris, K | 1 |
| Collins, A; Doerfler, L; Savas, J | 1 |
| Marchetti, MA; Marghoob, AA; Navarrete-Dechent, C | 1 |
| Boyle, GM; Cullen, JK; Parsons, PG; Simmons, JL | 1 |
| Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Merks, I; Mosterd, K; Nelemans, PJ | 1 |
| Conforti, C; Corneli, P; di Meo, N; Dianzani, C; Farinazzo, E; Giuffrida, R; Magaton Rizzi, G; Moret, A; Zalaudek, I | 1 |
| Bartenstein, DW; Fisher, J; Hawryluk, EB; Kroshinsky, D; Lilly, E; Moustafa, D; Su, KA | 1 |
| Fayne, R; Nanda, S; Nichols, A; Shen, J | 1 |
| Berking, C; Heppt, MV; Steeb, T | 1 |
| Ali, FR; Raza, SA | 1 |
| Dunkelly-Allen, N; Feldman, SR; Hansen, JB; Larsson, T; Veverka, KA | 1 |
| Baker, C; MacMahon, B; Sinclair, R; Spelman, L; Supranowicz, M | 1 |
| Aydin, AM; Chahoud, J; Cheryian, SK; Hajiran, A; Pow-Sang, JM; Spiess, PE; Zemp, L | 1 |
| Feldman, SR; Heron, CE | 1 |
| Ahmady, S; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ | 1 |
| Choi, S; Chung, KY; Oh, BH; Oh, Y; Roh, MR | 1 |
| Badiavas, EV; Gonzalez, AM; Kirsner, RS; Moore, K; Nagrani, N; Nahm, WJ; Nichols, AJ; Shen, J; Zito, PM | 1 |
| Asgari, MM; Bennett, DD; Connolly, SM; Dellavalle, RP; Eisen, DB; Frazer-Green, L; Freeman, EE; Goldenberg, G; Leffell, DJ; Malik, S; Peschin, S; Schlesinger, TE; Sligh, JE; Wu, PA | 2 |
| Cull, D; Emmerich, VK; Feldman, SR; Kelly, KA | 1 |
| Bennardo, F; Bennardo, L; Dastoli, S; Giudice, A; Morrone, P; Nisticò, SP; Passante, M; Patruno, C; Provenzano, E | 1 |
| Gupta, P; Kaur, M; Mehta Grewal, A; Sharma, M; Singh, H; Singh, M; Zadeng, Z | 1 |
| Brewer, JD; Lang, ME; Stewart, JR | 1 |
| Ahmed, I; Bowden, SJ; Gaunt, C; Gaunt, P; Green, AC; Harwood, CA; Hasan, ZU; Hogan, S; Homer, V; Ismail, F; Jefferson-Hulme, Y; Kentley, J; Lear, JT; Matin, RN; Milligan, A; Mitchell-Worsford, L; Proby, CM; Thomson, J; Van-de-Velde, V; Wheatley, K; Whitmarsh, T | 1 |
| Bjartling, C; Forslund, O; Kristiansen, S; Svensson, Å; Torbrand, C | 1 |
| Ciccarese, G; Drago, F; Parodi, A | 1 |
| Calzavara-Pinton, I; Calzavara-Pinton, P; Rossi, M; Rovati, C | 1 |
| Ahmady, S; Arits, AHMM; de Rooij, MJM; Essers, BAB; Jansen, MHE; Kelleners-Smeets, NWJ; Kessels, JPHM; Mosterd, K; Nelemans, PJ; Quaedvlieg, PJF | 1 |
| Cheng, B; Etzkorn, JR; Giordano, CN; Higgins, HW; Miller, CJ; Shin, TM; Sobanko, JF; Veerabagu, S | 1 |
| Algarin, YA; Jambusaria-Pahlajani, A; Patel, VA; Ruiz, E | 1 |
| Alam, M; Anvery, N; Christensen, RE; Dirr, MA; Harikumar, V; Poon, E; Reynolds, K; Worley, B; Yi, MD | 1 |
| Ljubojević Hadžavdić, S; Skerlev, M; Tomić, L | 1 |
| Arcuri, D; Iannattone, L; Lagacé, F; Lefrançois, P; Litvinov, IV; Netchiporouk, E; Ramchatesingh, B | 1 |
| DeSimone, JA; DiLorenzo, A; Lindberg, MR | 1 |
| Arthur, A; Badiavas, E; Kirsner, R; Nahm, W; Nichols, A; Rapoport, E; Shen, J; Wyant, W | 1 |
| Bauman, JE; Chow, HS; Desravines, N; House, M; Hsu, CH; Mohnot, S; O'Connor, S; Rahangdale, L; Sahasrabuddhe, V; Sauter, E | 1 |
| Krieter, M; Schultz, E | 1 |
70 review(s) available for fluorouracil and imiquimod
| Article | Year |
|---|---|
Therapeutic approaches to genital warts.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites; Antiviral Agents; Condylomata Acuminata; Cryotherapy; Drug Therapy, Combination; Electrosurgery; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferons; Keratolytic Agents; Laser Therapy; Papillomaviridae; Papillomavirus Infections; Podophyllin; Podophyllotoxin; Tumor Virus Infections | 1997 |
Topical therapy for actinic keratoses, I: 5-Fluorouracil and imiquimod.
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Keratosis; Precancerous Conditions; Randomized Controlled Trials as Topic; Skin Neoplasms | 2003 |
Current treatment patterns in non-melanoma skin cancer across Europe.
Topics: Administration, Cutaneous; Aminoquinolines; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Europe; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Skin Neoplasms | 2003 |
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
Topical and light-based treatments for actinic keratoses.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cyclooxygenase Inhibitors; Diclofenac; Fluorouracil; Humans; Hyaluronic Acid; Imiquimod; Keratosis; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Precancerous Conditions; Retinoids; Skin Neoplasms; Vitamin A | 2003 |
Established and potential strategies against papillomavirus infections.
Topics: Aminoquinolines; Antimetabolites; Antiviral Agents; Cidofovir; Cytosine; Drug Design; Fluorouracil; Humans; Imiquimod; Indoles; Interferon Inducers; Interferons; Organophosphonates; Organophosphorus Compounds; Papillomavirus Infections; Podophyllin; Viral Vaccines | 2004 |
Medical and surgical therapies for keloids.
Topics: Adrenal Cortex Hormones; Aminoquinolines; Fluorouracil; Humans; Imiquimod; Injections, Subcutaneous; Interferons; Keloid | 2004 |
Topical treatment strategies for non-melanoma skin cancer and precursor lesions.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Precancerous Conditions; Skin Neoplasms; Sunlight | 2004 |
Current and novel treatment options for actinic keratosis.
Topics: Aminolevulinic Acid; Aminoquinolines; Cryotherapy; Diclofenac; Fluorouracil; Gels; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2004 |
How and when to treat molluscum contagiosum and warts in children.
Topics: Adhesives; Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Cantharidin; Child; Cimetidine; Cryotherapy; Curettage; Fluorouracil; Hot Temperature; Humans; Imiquimod; Immunotherapy; Irritants; Keratolytic Agents; Laser Therapy; Molluscum Contagiosum; Occlusive Dressings; Pediatrics; Podophyllin; Salicylic Acid; Tretinoin; Warts | 2005 |
Mechanisms of action of new treatment modalities for actinic keratosis.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites; Antineoplastic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Randomized Controlled Trials as Topic; Teratogens | 2006 |
Evaluation of the effectiveness of imiquimod and 5-fluorouracil for the treatment of actinic keratosis: Critical review and meta-analysis of efficacy studies.
Topics: Adjuvants, Immunologic; Aminoquinolines; Clinical Trials, Phase III as Topic; Confidence Intervals; Facial Dermatoses; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Keratosis; Ointments; Photosensitivity Disorders; Scalp Dermatoses; Time Factors | 2005 |
Actinic keratoses: sequelae and treatments. Recommendations from a consensus panel.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Consensus Development Conferences as Topic; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photosensitivity Disorders; Practice Guidelines as Topic; Risk Factors; Skin Neoplasms; Ultraviolet Rays | 2006 |
Extramammary Paget's disease resistant to surgery and imiquimod monotherapy but responsive to imiquimod combination topical chemotherapy with 5-fluorouracil and retinoic acid: a case report.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Diagnosis, Differential; Fluorouracil; Genital Neoplasms, Male; Humans; Imiquimod; Male; Paget Disease, Extramammary; Tretinoin | 2006 |
[Actinic keratosis].
Topics: Adjuvants, Immunologic; Age Factors; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Humans; Imiquimod; Interferon Inducers; Keratosis; Laser Therapy; Male; Ointments; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Time Factors; Ultraviolet Rays | 2006 |
Guidelines for management of Bowen's disease: 2006 update.
Topics: Adjuvants, Immunologic; Aminoquinolines; Bowen's Disease; Cautery; Cryotherapy; Curettage; Disease Progression; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Laser Therapy; Photochemotherapy; Risk Factors; Skin Neoplasms | 2007 |
Therapeutic options for Bowen's disease.
Topics: Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cautery; Cryotherapy; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2007 |
Treatment options for actinic keratoses.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chemexfoliation; Cryosurgery; Curettage; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Prevalence; Skin Neoplasms | 2007 |
Nevoid basal cell carcinoma syndrome (Gorlin syndrome): updated review of minimally invasive treatments.
Topics: Aminoquinolines; Antineoplastic Agents; Basal Cell Nevus Syndrome; Carcinoma, Basal Cell; Cryosurgery; Electrochemotherapy; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Interferons; Photochemotherapy; Randomized Controlled Trials as Topic; Retinoids; Skin Neoplasms | 2008 |
Topical therapy for actinic keratoses: current and evolving therapies.
Topics: Administration, Cutaneous; Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Colchicine; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Neoplasms, Squamous Cell; Retinoids; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2006 |
Actinic keratoses.
Topics: Aged; Aminoquinolines; Carcinoma, Squamous Cell; Cryotherapy; Dermatology; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Lasers; Medical Oncology; Models, Biological; Organ Transplantation; Photochemotherapy; Retinoids; Skin Neoplasms | 2009 |
Topical treatment of field cancerization.
Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppression Therapy; Immunosuppressive Agents; Keratosis, Actinic; Organ Transplantation; Photochemotherapy; Recurrence; Skin Neoplasms; Tissue Distribution | 2009 |
Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Metabolic Clearance Rate; Skin Neoplasms | 2009 |
Treating skin cancer with topical cream.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Retinoids; Skin Neoplasms | 2010 |
Actinic keratoses: past, present and future.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Cryosurgery; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keratosis, Actinic; Photochemotherapy; Precancerous Conditions; Skin Neoplasms | 2010 |
Disseminated superficial actinic porokeratosis: a treatment review.
Topics: Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cholecalciferol; Diclofenac; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Interferon Inducers; Laser Therapy; Photochemotherapy; Photosensitizing Agents; Porokeratosis; Retinoids; Vitamins | 2012 |
Actinic cheilitis: a treatment review.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Caustics; Cheilitis; Cryosurgery; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip; Photochemotherapy; Precancerous Conditions; Risk Factors; Skin Neoplasms; Trichloroacetic Acid | 2010 |
Topical antineoplastic agents in the treatment of mucocutaneous diseases.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mucositis; Mucous Membrane; Skin Diseases; Skin Neoplasms | 2011 |
Do lasers or topicals really work for nonmelanoma skin cancers?
Topics: Administration, Cutaneous; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemexfoliation; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Laser Therapy; Nicotinic Acids; Paget Disease, Extramammary; Photochemotherapy; Skin Neoplasms | 2011 |
Basic pharmacology of topical imiquimod, 5-fluorouracil, and diclofenac for the dermatologic surgeon.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2012 |
Emerging treatments and signaling pathway inhibitors.
Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Basal Cell Nevus Syndrome; Benzamides; Carcinoma, Basal Cell; Deoxyribonuclease (Pyrimidine Dimer); Fluorouracil; Hedgehog Proteins; Humans; Imiquimod; Photochemotherapy; Pyridines; Quinazolines; Retinoids; Secondary Prevention; Signal Transduction; Skin Neoplasms; Viral Proteins | 2011 |
[Comparative assessment of the methods of treatment of Condylomata acuminata].
Topics: Alphapapillomavirus; Aminoquinolines; Antimetabolites; Caustics; Condylomata Acuminata; Cryotherapy; Electrosurgery; Female; Fluorouracil; Genital Diseases, Female; Humans; Imiquimod; Interferon Inducers; Podophyllin; Trichloroacetic Acid | 2011 |
Topical therapies for periorbital cutaneous malignancies: indications and treatment regimens.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Diterpenes; Fluorouracil; Humans; Imiquimod; Mitomycin; Orbital Neoplasms; Skin Neoplasms | 2012 |
Treatment options for anal intraepithelial neoplasia and evidence for their effectiveness.
Topics: Adult; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Anus Neoplasms; Cidofovir; Comorbidity; Cytosine; Female; Fluorouracil; Global Health; HIV Infections; Homosexuality, Male; Humans; Imiquimod; Incidence; Male; Organophosphonates; Papillomavirus Infections; Precancerous Conditions; Trichloroacetic Acid | 2012 |
Diagnosis and treatment of Basal cell and squamous cell carcinoma.
Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryotherapy; Curettage; Dermatologic Surgical Procedures; Desiccation; Fluorouracil; Humans; Imiquimod; Mohs Surgery; Risk Factors; Skin; Skin Neoplasms | 2012 |
Microinvasive melanoma: cutaneous pharmacotherapeutic approaches.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Biopsy, Needle; Dicarboxylic Acids; Female; Fluorouracil; Geriatric Assessment; Humans; Imiquimod; Immunohistochemistry; Interferon-alpha; Male; Melanoma; Neoplasm Invasiveness; Pharmaceutical Preparations; Prognosis; Risk Assessment; Skin Neoplasms; Survival Analysis; Treatment Outcome | 2013 |
Network meta-analysis of the outcome 'participant complete clearance' in nonimmunosuppressed participants of eight interventions for actinic keratosis: a follow-up on a Cochrane review.
Topics: Adjuvants, Immunologic; Aged; Aminolevulinic Acid; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Cryotherapy; Diclofenac; Diterpenes; Drug Combinations; Female; Fluorouracil; Follow-Up Studies; Humans; Hyaluronic Acid; Imiquimod; Immunocompetence; Immunosuppressive Agents; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Randomized Controlled Trials as Topic; Treatment Outcome | 2013 |
Pharmacotherapeutic management of actinic keratosis: focus on newer topical agents.
Topics: Administration, Topical; Aminoquinolines; Cryotherapy; Diclofenac; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Severity of Illness Index; Treatment Outcome | 2013 |
Interventions for cutaneous Bowen's disease.
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Cryotherapy; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2013 |
Topical and intralesional treatment of nonmelanoma skin cancer: efficacy and cost comparisons.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Bleomycin; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferon alpha-2; Interferon-alpha; Keratoacanthoma; Methotrexate; Recombinant Proteins; Skin Neoplasms | 2013 |
Strategic management of keloid disease in ethnic skin: a structured approach supported by the emerging literature.
Topics: Aminoquinolines; Bleomycin; Cryosurgery; Dermatologic Agents; Electric Stimulation; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Keloid; Medical History Taking; Photochemotherapy; Physical Examination; Secondary Prevention; Silicone Gels; Steroids | 2013 |
Anal squamous intraepithelial neoplasia.
Topics: Adjuvants, Immunologic; Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Papillomavirus Infections; Papillomavirus Vaccines; Photochemotherapy; Watchful Waiting | 2013 |
Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminoquinolines; Anti-Inflammatory Agents; Antineoplastic Agents; Bleomycin; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Cryotherapy; Disease Management; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Interferons; Keloid; Lasers, Dye; Low-Level Light Therapy; Neuromuscular Agents; ortho-Aminobenzoates | 2014 |
Photodynamic therapy in the treatment of basal cell carcinoma: a systematic review and meta-analysis.
Topics: Administration, Topical; Aminoquinolines; Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Incidence; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms; Time Factors | 2015 |
Conventional treatment of actinic keratosis: an overview.
Topics: Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy | 2015 |
Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Skin Neoplasms | 2015 |
New Topical Treatment Options for Actinic Keratosis: A Systematic Review.
Topics: Administration, Cutaneous; Aminoquinolines; Dermatologic Agents; Diterpenes; Drug Combinations; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Randomized Controlled Trials as Topic; Salicylic Acid; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
[Diagnosis and treatment of actinic keratosis].
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Precancerous Conditions; Primary Health Care | 2015 |
Keloids and Hypertrophic Scars: A Spectrum of Clinical Challenges.
Topics: Adjuvants, Immunologic; Aminoquinolines; Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites; Bleomycin; Cell Proliferation; Cicatrix, Hypertrophic; Clinical Trials as Topic; Collagen; Combined Modality Therapy; Cryotherapy; Extracellular Matrix; Fibroblasts; Fluorouracil; Glucocorticoids; Humans; Imiquimod; Inflammation; Keloid; Laser Therapy; Wound Healing | 2016 |
Treatment of Basal Cell Carcinoma in the Elderly: What Nondermatologists Need to Know.
Topics: Aminoquinolines; Anilides; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Dermatologic Surgical Procedures; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Pyridines; Radiotherapy; Skin Neoplasms | 2016 |
Laser-Assisted Drug Delivery.
Topics: Administration, Cutaneous; Adrenergic beta-Antagonists; Aminolevulinic Acid; Aminoquinolines; Analgesics; Antibodies; Antineoplastic Agents; Ascorbic Acid; Cyclopropanes; Dermatologic Agents; Drug Delivery Systems; Fluorouracil; Humans; Imiquimod; Immunotherapy; Laser Therapy; Methotrexate; Minoxidil; Permeability; Photosensitizing Agents; Polyesters; RNA, Small Interfering; Skin; Timolol; Vaccines | 2016 |
Resistance of Nonmelanoma Skin Cancer to Nonsurgical Treatments. Part I: Topical Treatments.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antigen-Presenting Cells; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dermatologic Agents; Diclofenac; Diterpenes; Drug Resistance, Neoplasm; Fluorouracil; Humans; Imiquimod; Meta-Analysis as Topic; Neoplasm Proteins; Neoplastic Stem Cells; Skin Neoplasms | 2016 |
A Network Meta-Analysis of Non-Melanoma Skin Cancer (NMSC) Treatments: Efficacy and Safety Assessment.
Topics: Aminoquinolines; Cryotherapy; Fluorouracil; Humans; Imiquimod; Melanoma; Photochemotherapy; PubMed; Skin Neoplasms | 2017 |
Nonsurgical Therapies for Basal Cell Carcinoma: A Review.
Topics: Administration, Cutaneous; Aminoquinolines; Anilides; Antineoplastic Agents; Biphenyl Compounds; Carcinoma, Basal Cell; Clinical Trials as Topic; Fluorouracil; Humans; Imiquimod; Interferons; Meta-Analysis as Topic; Molecular Targeted Therapy; Neoplasm Invasiveness; Photochemotherapy; Pyridines; Randomized Controlled Trials as Topic; Risk Assessment; Skin Neoplasms | 2017 |
Actinic keratosis - review for clinical practice.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antimetabolites, Antineoplastic; Antineoplastic Agents; Cryotherapy; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Retinoids | 2019 |
Mediators of Inflammation in Topical Therapy of Skin Cancers.
Topics: Administration, Topical; Aminoquinolines; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cytokines; Diterpenes; Fluorouracil; Humans; Imiquimod; Inflammation; Melanoma; Neoplasm Metastasis; Skin; Skin Neoplasms; Toll-Like Receptor 7 | 2019 |
Topical and Systemic Modalities for Chemoprevention of Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Administration, Oral; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Chemoprevention; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Niacinamide; Photochemotherapy; Retinoids; Skin Neoplasms | 2019 |
Treatments of actinic cheilitis: A systematic review of the literature.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Dermabrasion; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Laser Therapy; Lip Neoplasms; Photochemotherapy; Precancerous Conditions; Treatment Outcome | 2020 |
Nonsurgical Treatments for Nonmelanoma Skin Cancer.
Topics: Administration, Cutaneous; Anilides; Antineoplastic Agents; Antineoplastic Agents, Immunological; Biphenyl Compounds; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Cryosurgery; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Programmed Cell Death 1 Receptor; Pyridines; Radiotherapy; Skin Neoplasms; Watchful Waiting | 2019 |
Topical treatments for skin cancer.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Diterpenes; Drug Delivery Systems; Fluorouracil; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Keratosis, Actinic; Melanoma; Neoplasms, Squamous Cell; Photochemotherapy; Retinoids; Skin; Skin Neoplasms; Ultraviolet Rays | 2020 |
Current therapies for actinic keratosis.
Topics: Aftercare; Carcinoma, Squamous Cell; Chemexfoliation; Cryotherapy; Curettage; Dermoscopy; Diclofenac; Disease Progression; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy; Practice Guidelines as Topic; Protective Clothing; Skin; Skin Neoplasms; Sunlight; Sunscreening Agents | 2020 |
A review of actinic keratosis, skin field cancerisation and the efficacy of topical therapies.
Topics: Antineoplastic Agents; Diclofenac; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Recurrence; Skin Neoplasms | 2021 |
Guidelines of care for the management of actinic keratosis.
Topics: Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy | 2021 |
Guidelines of care for the management of actinic keratosis: Executive summary.
Topics: Cryosurgery; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Practice Guidelines as Topic | 2021 |
Local Chemotherapy as an Adjuvant Treatment in Unresectable Squamous Cell Carcinoma: What Do We Know So Far?
Topics: Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Skin Neoplasms | 2021 |
Efficacy of nonexcisional treatment modalities for superficially invasive and in situ squamous cell carcinoma: A systematic review and meta-analysis.
Topics: Carcinoma in Situ; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2022 |
Topical Pharmacotherapy for Actinic Keratoses in Older Adults.
Topics: Aged; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Treatment Outcome | 2022 |
Advances in Topical Treatments of Cutaneous Malignancies.
Topics: Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Quality of Life; Skin Neoplasms | 2023 |
Treatment of actinic keratosis: a systematic review.
Topics: Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms; Treatment Outcome | 2023 |
Pharmacological Agents Used in the Prevention and Treatment of Actinic Keratosis: A Review.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome | 2023 |
17 trial(s) available for fluorouracil and imiquimod
| Article | Year |
|---|---|
Fluorouracil does not improve the outcome of imiquimoid treatment of vulval intraepethelial neoplasia.
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Prospective Studies; Treatment Outcome; Vulvar Neoplasms | 2005 |
Comparison of 5% 5-fluorouracil cream and 5% imiquimod cream in the management of actinic keratoses on the face and scalp.
Topics: Administration, Topical; Adult; Aminoquinolines; Disease Management; Erythema; Facial Dermatoses; Fluorouracil; Humans; Imiquimod; Keratosis; Scalp Dermatoses; Treatment Outcome | 2007 |
The treatment of actinic keratoses with a combination of 5-fluorouracil and imiquimod creams.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Emollients; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunosuppressive Agents; Keratosis; Male; Middle Aged; Patient Dropouts; Time Factors; Treatment Outcome | 2007 |
A randomised study of topical 5% imiquimod vs. topical 5-fluorouracil vs. cryosurgery in immunocompetent patients with actinic keratoses: a comparison of clinical and histological outcomes including 1-year follow-up.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Squamous Cell; Cryosurgery; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Immunocompetence; Keratosis; Male; Middle Aged; Neoplasms, Radiation-Induced; Skin Neoplasms; Treatment Outcome; Ultraviolet Rays | 2007 |
Topical treatment of cutaneous metastases of malignant melanoma using combined imiquimod and 5-fluorouracil.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Humans; Imiquimod; Melanoma; Neoplasm Metastasis; Skin Neoplasms; Skin Ulcer; Treatment Outcome | 2012 |
Comparison of imiquimod, topical fluorouracil, and electrocautery for the treatment of anal intraepithelial neoplasia in HIV-positive men who have sex with men: an open-label, randomised controlled trial.
Topics: Aminoquinolines; Anus Neoplasms; Carcinoma in Situ; Electrocoagulation; Fluorouracil; HIV; HIV Infections; HIV Seropositivity; Homosexuality, Male; Humans; Imiquimod; Male; Middle Aged; Netherlands; Papillomaviridae; Prospective Studies | 2013 |
Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Prognosis; Single-Blind Method; Skin Neoplasms | 2013 |
A double-blind, randomized, placebo-controlled trial of oral isotretinoin in the treatment of recalcitrant facial flat warts.
Topics: Administration, Oral; Adolescent; Adult; Aminoquinolines; Cryotherapy; Dermatologic Agents; Double-Blind Method; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Isotretinoin; Male; Treatment Outcome; Warts; Young Adult | 2015 |
Cost-effectiveness of topical imiquimod and fluorouracil vs. photodynamic therapy for treatment of superficial basal-cell carcinoma.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Cost Savings; Cost-Benefit Analysis; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2014 |
Three-Year Follow-Up Results of Photodynamic Therapy vs. Imiquimod vs. Fluorouracil for Treatment of Superficial Basal Cell Carcinoma: A Single-Blind, Noninferiority, Randomized Controlled Trial.
Topics: Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Disease-Free Survival; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Proportional Hazards Models; Single-Blind Method; Skin Neoplasms; Treatment Outcome | 2016 |
Patient preferences for the attributes of a noninvasive treatment for superficial basal cell carcinoma: a discrete choice experiment.
Topics: Aminolevulinic Acid; Carcinoma, Basal Cell; Choice Behavior; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Patient Preference; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome | 2018 |
Comparison of long-term cosmetic outcomes for different treatments of superficial basal cell carcinoma.
Topics: Adult; Aged; Carcinoma, Basal Cell; Dermatologic Surgical Procedures; Esthetics; Female; Fluorouracil; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Netherlands; Photochemotherapy; Risk Assessment; Skin Neoplasms; Time Factors; Treatment Outcome | 2018 |
Randomized Trial of Four Treatment Approaches for Actinic Keratosis.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Follow-Up Studies; Gels; Humans; Imiquimod; Intention to Treat Analysis; Keratosis, Actinic; Male; Middle Aged; Patient Compliance; Photochemotherapy; Photosensitizing Agents; Proportional Hazards Models; Scalp Dermatoses; Single-Blind Method; Skin Cream; Treatment Outcome | 2019 |
A trial-based cost-effectiveness analysis of topical 5-fluorouracil vs. imiquimod vs. ingenol mebutate vs. methyl aminolaevulinate conventional photodynamic therapy for the treatment of actinic keratosis in the head and neck area performed in the Netherla
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Treatment Outcome | 2020 |
The Effect of Four Approaches to Treat Actinic Keratosis on the Health-Related QOL, as Assessed by the Skindex-29 and Actinic Keratosis QOL.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Patient Reported Outcome Measures; Photochemotherapy; Quality of Life; Skin Cream; Surveys and Questionnaires; Treatment Outcome | 2021 |
Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
Topics: Carcinoma, Squamous Cell; Feasibility Studies; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Organ Transplantation; Sunscreening Agents; Transplant Recipients; Treatment Outcome | 2022 |
Risk of Invasive Cutaneous Squamous Cell Carcinoma After Different Treatments for Actinic Keratosis: A Secondary Analysis of a Randomized Clinical Trial.
Topics: Aged; Carcinoma, Squamous Cell; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Skin Neoplasms; Treatment Outcome | 2022 |
69 other study(ies) available for fluorouracil and imiquimod
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Imiquimod and 5% fluorouracil therapy for anal and perianal squamous cell carcinoma in situ in an HIV-1-positive man.
Topics: Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Anus Neoplasms; Carcinoma in Situ; Carcinoma, Squamous Cell; Drug Administration Schedule; Fluorouracil; HIV Infections; HIV-1; Humans; Imiquimod; Male; Middle Aged | 2001 |
Squamous cell carcinoma in situ (Bowen's disease) in renal transplant patients treated with 5% imiquimod and 5% 5-fluorouracil therapy.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Drug Administration Schedule; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Kidney Transplantation; Leg; Male; Middle Aged; Pilot Projects; Skin Neoplasms; Survivors; Treatment Outcome | 2001 |
New treatments for actinic keratoses.
Topics: Administration, Topical; Aminolevulinic Acid; Aminoquinolines; Dermatologic Agents; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Sunscreening Agents; United States | 2002 |
Can you tell me more about topical treatments for skin cancer?
Topics: Administration, Cutaneous; Aminoquinolines; Antineoplastic Agents; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2005 |
Topical combination therapy for cutaneous squamous cell carcinoma in situ with 5-fluorouracil cream and imiquimod cream in patients who have failed topical monotherapy.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Squamous Cell; Cytokines; Drug Evaluation; Drug Synergism; Fingers; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Prodrugs; Remission Induction; Skin Neoplasms; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2006 |
Basal cell carcinoma.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Causality; Cryosurgery; Curettage; Diagnosis, Differential; Electrosurgery; Female; Fluorouracil; Humans; Imiquimod; Information Services; Interferon alpha-2; Interferon-alpha; Internet; Leg; Mohs Surgery; Nurse's Role; Patient Education as Topic; Recombinant Proteins; Skin Care; Skin Neoplasms | 2006 |
Pharmacoeconomic analysis of the treatment of multiple actinic keratoses.
Topics: Aminolevulinic Acid; Aminoquinolines; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cryotherapy; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis; Photochemotherapy; Treatment Outcome | 2008 |
An economic evaluation of topical treatments for actinic keratosis.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Cost-Benefit Analysis; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Models, Economic; Photochemotherapy; Photosensitizing Agents; Treatment Outcome; United Kingdom | 2009 |
Combination therapy with imiquimod, 5-fluorouracil, and tazarotene in the treatment of extensive radiation-induced Bowen's disease of the hands.
Topics: Aminoquinolines; Antineoplastic Agents; Biopsy; Bowen's Disease; Dermatologic Agents; Dose-Response Relationship, Drug; Drug Administration Routes; Drug Therapy, Combination; Fluorouracil; Follow-Up Studies; Hand; Humans; Imiquimod; Male; Middle Aged; Neoplasms, Radiation-Induced; Nicotinic Acids; Skin Neoplasms | 2010 |
Current management of actinic keratoses.
Topics: Administration, Cutaneous; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Squamous Cell; Diclofenac; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2010 |
Agreement on the clinical diagnosis and management of cutaneous squamous neoplasms.
Topics: Algorithms; Aminoquinolines; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cryosurgery; Curettage; Dermatology; Diagnosis, Differential; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Mohs Surgery; Photochemotherapy; Precancerous Conditions; Reproducibility of Results; Skin Neoplasms; Terminology as Topic; United States | 2010 |
Mild clinical phenotype of Kindler syndrome associated with late diagnosis and skin cancer.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Basement Membrane; Blister; Carcinoma, Basal Cell; Cryosurgery; Delayed Diagnosis; Epidermolysis Bullosa; Female; Fluorouracil; Homozygote; Humans; Imiquimod; Male; Membrane Proteins; Middle Aged; Mutation; Neoplasm Proteins; Neoplasm Recurrence, Local; Neoplasms, Squamous Cell; Periodontal Diseases; Photosensitivity Disorders; Skin Neoplasms | 2010 |
[Surgical vs nonsurgical treatment of basal cell carcinoma].
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryosurgery; Fluorouracil; Follow-Up Studies; Hedgehog Proteins; Humans; Imiquimod; Interferons; Laser Therapy; Mohs Surgery; Neoplasm Recurrence, Local; Photochemotherapy; Phytotherapy; Plant Preparations; Risk Factors; Semecarpus; Skin Neoplasms; Treatment Outcome | 2010 |
Porokeratosis of Mibelli: Successful treatment with 5 percent topical imiquimod and topical 5 percent 5-fluorouracil.
Topics: Administration, Cutaneous; Aged, 80 and over; Aminoquinolines; Antimetabolites; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Immunologic Factors; Leg; Male; Porokeratosis; Precancerous Conditions; Remission Induction; Skin Neoplasms | 2010 |
Actinic keratosis. Patient-based approaches to adverse event management.
Topics: Administration, Topical; Aminoquinolines; Combined Modality Therapy; Cryotherapy; Dermatologic Agents; Diclofenac; Electrosurgery; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photosensitizing Agents | 2010 |
What's new in treatment of keloids? New applications for common therapies, new treatments to come.
Topics: Adjuvants, Immunologic; Aminoquinolines; Fluorouracil; Humans; Imiquimod; Immunosuppressive Agents; Keloid; Secondary Prevention; Treatment Outcome | 2011 |
Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma.
Topics: Adult; Aged; Aminoquinolines; Carcinoma, Basal Cell; Esthetics; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Reproducibility of Results; Skin Neoplasms | 2013 |
Solar cheilosis: an ominous precursor part II. Therapeutic perspectives.
Topics: Administration, Topical; Aminoquinolines; Biopsy; Carcinoma, Squamous Cell; Cheilitis; Combined Modality Therapy; Diagnosis, Differential; Diclofenac; Female; Fluorouracil; Humans; Imiquimod; Lip Neoplasms; Male; Middle Aged; Precancerous Conditions; Skin Neoplasms; Sunlight | 2012 |
Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents.
Topics: Administration, Cutaneous; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Retrospective Studies; Time Factors; Treatment Outcome | 2012 |
Treatment-refractory actinic keratoses successfully treated using simultaneous combination topical 5-fluorouracil cream and imiquimod cream: a case-control study.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Analysis of Variance; Antimetabolites, Antineoplastic; Antineoplastic Agents; Case-Control Studies; Chi-Square Distribution; Cryosurgery; Drug Therapy, Combination; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Retrospective Studies; Treatment Failure | 2012 |
[Emerging strategies for the prevention and therapy of excessive scars].
Topics: Adjuvants, Immunologic; Adrenal Cortex Hormones; Aminoquinolines; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Cryosurgery; Esthetics; Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Keloid; Laser Therapy; Plastic Surgery Procedures; Risk Factors | 2012 |
Patients' perceptions of topical treatments of actinic keratosis.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Diclofenac; Female; Fluorouracil; Gels; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Patient Acceptance of Health Care; Photochemotherapy; Precancerous Conditions; Skin Cream | 2014 |
Temporal trends in genital warts among individuals covered by the public prescription drug insurance plan in the province of Quebec, Canada, from 1998 to 2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents, Phytogenic; Antiviral Agents; Condylomata Acuminata; Drug Prescriptions; Drug Utilization; Female; Fluorouracil; Humans; Imiquimod; Incidence; Insurance Claim Review; Male; Middle Aged; Podophyllotoxin; Prevalence; Quebec; Young Adult | 2013 |
One step towards standardised management of anal dysplasia.
Topics: Aminoquinolines; Anus Neoplasms; Electrocoagulation; Fluorouracil; Homosexuality, Male; Humans; Imiquimod; Male | 2013 |
Treating basal-cell carcinoma in a real life setting.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2013 |
Key Opinion Leader (KOL) Consensus for actinic keratosis management in Italy: the AKTUAL Workshop.
Topics: Aminoquinolines; Carcinoma, Squamous Cell; Case Management; Clinical Trials as Topic; Cryosurgery; Diagnosis, Differential; Diclofenac; Disease Management; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Italy; Keratosis, Actinic; Laser Therapy; Neoplasms, Radiation-Induced; Photochemotherapy; Practice Guidelines as Topic; Skin Neoplasms; Sunscreening Agents; United Kingdom; United States; Watchful Waiting | 2013 |
British Association of Dermatologists' guidelines for the management of squamous cell carcinoma in situ (Bowen's disease) 2014.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Bowen's Disease; Cautery; Combined Modality Therapy; Costs and Cost Analysis; Cryotherapy; Curettage; Fluorouracil; Forecasting; Humans; Imiquimod; Laser Therapy; Male; Mohs Surgery; Nail Diseases; Penile Neoplasms; Photochemotherapy; Skin Neoplasms | 2014 |
Two sisters reveal autosomal recessive inheritance of epidermodysplasia verruciformis: a case report.
Topics: Adult; Alphapapillomavirus; Aminoquinolines; Antiviral Agents; Epidermodysplasia Verruciformis; Female; Fluorouracil; Genes, Recessive; Humans; Imiquimod; Membrane Proteins; Mutation; Siblings; Virion; Young Adult | 2014 |
Field cancerization: from molecular basis to selective field-directed management of actinic keratosis.
Topics: Administration, Topical; Aminoquinolines; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Skin Neoplasms | 2015 |
Imiquimod induces sustained remission of actinic damage: a case report spanning one decade of observation.
Topics: Administration, Topical; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Skin Neoplasms | 2015 |
Tumor thickness and adnexal extension of superficial basal cell carcinoma (sBCC) as determinants of treatment failure for methylaminolevulinate (MAL)-photodynamic therapy (PDT), imiquimod, and 5-fluorouracil (FU).
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Skin Neoplasms; Treatment Failure; Tumor Burden | 2015 |
Real-life Data on Patient Characteristics, Cost and Effectiveness of Field-directed Treatment for Actinic Keratoses: An Observational Study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Aminoquinolines; Cost-Benefit Analysis; Dermatologic Agents; Drug Costs; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Netherlands; Patient Preference; Photochemotherapy; Photosensitizing Agents; Remission Induction; Severity of Illness Index; Time Factors; Treatment Outcome | 2016 |
Methods and Results Report - Evidence and consensus-based (S3) Guidelines for the Treatment of Actinic Keratosis -International League of Dermatological Societies in cooperation with the European Dermatology Forum.
Topics: Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Curettage; Cyclooxygenase Inhibitors; Diclofenac; Diterpenes; Evidence-Based Medicine; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Lasers, Gas; Photochemotherapy | 2015 |
Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study.
Topics: Aminolevulinic Acid; Aminoquinolines; Animals; Calcitriol; Carcinoma, Squamous Cell; Female; Fluorouracil; Imiquimod; Mice; Mice, Hairless; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Skin; Skin Neoplasms; Ultraviolet Rays | 2016 |
Five-Year Results of a Randomized Controlled Trial Comparing Effectiveness of Photodynamic Therapy, Topical Imiquimod, and Topical 5-Fluorouracil in Patients with Superficial Basal Cell Carcinoma.
Topics: Administration, Cutaneous; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Ointments; Photochemotherapy; Skin Neoplasms | 2018 |
Imiquimoid 5%: In Pursuit of New Treatment Regimens for Actinic Keratosis.
Topics: Clinical Protocols; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic | 2018 |
Cells to Surgery Quiz: January 2018.
Topics: Administration, Cutaneous; Arm; Arm Injuries; Bleomycin; Botulinum Toxins, Type A; Cicatrix, Hypertrophic; Dermatologic Agents; Fingolimod Hydrochloride; Fluorouracil; Humans; Imiquimod; Signal Transduction; Skin | 2018 |
A real-world, community-based cohort study comparing the effectiveness of topical fluorouracil versus topical imiquimod for the treatment of actinic keratosis.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminoquinolines; Cohort Studies; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Comparing Topical Treatments for Basal Cell Carcinoma.
Topics: Aminolevulinic Acid; Aminoquinolines; Carcinoma, Basal Cell; Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms | 2018 |
Cells to Surgery Quiz: July 2018.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antineoplastic Agents; Carcinoma, Basal Cell; Disease-Free Survival; Drug Eruptions; Equivalence Trials as Topic; Face; Fluorouracil; Humans; Imiquimod; Male; Photochemotherapy; Photosensitizing Agents; Skin Cream; Skin Neoplasms; Treatment Outcome | 2018 |
Evaluation of the treatment costs and duration of topical treatments for multiple actinic keratosis based on the area of the cancerization field and not on the number of lesions.
Topics: Administration, Topical; Aminolevulinic Acid; Cohort Studies; Cost of Illness; Diclofenac; Diterpenes; Drug Administration Schedule; Female; Fluorouracil; Health Care Costs; Humans; Imiquimod; Italy; Keratosis, Actinic; Male; Photochemotherapy; Precancerous Conditions; Retrospective Studies; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2019 |
Comparative effectiveness of treatment of actinic keratosis with topical fluorouracil and imiquimod in the prevention of keratinocyte carcinoma: A cohort study.
Topics: Administration, Cutaneous; Aged; California; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Comparative Effectiveness Research; Female; Fluorouracil; Humans; Imiquimod; Intention to Treat Analysis; Keratinocytes; Keratosis, Actinic; Longitudinal Studies; Male; Middle Aged; Retrospective Studies; Risk Factors; Skin Neoplasms | 2019 |
Histologic subtype of treatment failures after noninvasive therapy for superficial basal cell carcinoma: An observational study.
Topics: Aged; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Antineoplastic Agents; Carcinoma, Basal Cell; Equivalence Trials as Topic; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Skin Neoplasms; Treatment Failure | 2019 |
Topical Combination of Fluorouracil and Calcipotriene as a Palliative Therapy for Refractory Extramammary Paget Disease.
Topics: Administration, Topical; Aged; Antineoplastic Combined Chemotherapy Protocols; Calcitriol; Female; Fluorouracil; Humans; Imiquimod; Middle Aged; Paget Disease, Extramammary; Palliative Care; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2019 |
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cost-Benefit Analysis; Cryotherapy; Dermatologic Agents; Diclofenac; Diterpenes; Electrocoagulation; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Laser Therapy; Photochemotherapy | 2019 |
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Cryotherapy; Dermatologic Agents; Fluorouracil; Humans; Imiquimod; Immunocompromised Host; Immunosuppressive Agents; Keratosis, Actinic; Laser Therapy; Niacinamide; Phototherapy; Transplant Recipients | 2019 |
Addressing the Challenges of Treating Actinic Keratosis
Topics: Dermatologic Agents; Disease Progression; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy | 2019 |
Contemporary management of actinic keratosis.
Topics: Carcinoma, Squamous Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms | 2021 |
A pediatric approach to management of skin growths in basal cell nevus syndrome.
Topics: Aminoquinolines; Basal Cell Nevus Syndrome; Child; Child, Preschool; Fluorouracil; Humans; Imiquimod; Skin Neoplasms | 2020 |
Combination Topical Chemotherapy for the Treatment of an Invasive Cutaneous Squamous Cell Carcinoma
Topics: Administration, Cutaneous; Aged, 80 and over; Carcinoma, Squamous Cell; Combined Modality Therapy; Diagnosis, Differential; Ear, External; Fluorouracil; Humans; Imiquimod; Male; Mohs Surgery; Skin Neoplasms | 2020 |
Cash is king: the balance of costs and effectiveness of treatments for actinic keratosis.
Topics: Aminolevulinic Acid; Cost-Benefit Analysis; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Netherlands; Photochemotherapy | 2020 |
Comparison of efficacy of field treatments for actinic keratoses.
Topics: Adult; Aminolevulinic Acid; Diterpenes; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Scalp Dermatoses | 2020 |
Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis.
Topics: Administration, Cutaneous; Aged; Antineoplastic Agents; Combined Modality Therapy; Cryotherapy; Diterpenes; Female; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Skin; Treatment Outcome; United States | 2020 |
Topical chemotherapy for penile carcinoma in situ: Contemporary outcomes and reported toxicity.
Topics: Administration, Topical; Adult; Aged; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Cohort Studies; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Penile Neoplasms; Treatment Outcome | 2021 |
Ingenol Mebutate and the Treatment of Actinic Keratosis.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Clinical Trials as Topic; Diterpenes; Fluorouracil; Humans; Imiquimod; Incidence; Keratosis, Actinic; Patient Preference; Photochemotherapy; Photosensitizing Agents; Risk Assessment; Skin Neoplasms; Treatment Outcome | 2021 |
Initial topical monotherapy may increase the risk of recurrence in patients with extramammary Paget's disease.
Topics: Fluorouracil; Humans; Imiquimod; Neoplasm Recurrence, Local; Paget Disease, Extramammary; Retrospective Studies | 2021 |
A Non-Surgical and Cost-Effective Treatment Approach Employing Topical Imiquimod, 5-Fluorouracil, and Tretinoin for Primary Non-Melanoma Skin Cancers.
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Cost-Benefit Analysis; Cryotherapy; Female; Fluorouracil; Humans; Imiquimod; Male; Middle Aged; Neoplasm Recurrence, Local; Retrospective Studies; Skin Neoplasms; Treatment Outcome; Tretinoin | 2021 |
Patient assessment of 5-fluorouracil and imiquimod for the treatment of actinic keratoses: a retrospective study of real-world effectiveness.
Topics: Aminoquinolines; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Retrospective Studies; Treatment Outcome | 2022 |
Long-term efficacy and safety of imiquimod 5% and fluorouracil 1% creams in medical monotherapy of complex eyelid basal cell carcinomas.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelids; Fluorouracil; Humans; Imiquimod; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Incidence of penile intraepithelial neoplasia and treatment strategies in Sweden 2000-2019.
Topics: Adult; Carcinoma in Situ; Fluorouracil; Humans; Imiquimod; Incidence; Male; Penile Neoplasms; Sweden; Young Adult | 2022 |
5-Fluorouracil 0.5%/salicylic acid 10% solution in the treatment of ano-genital warts.
Topics: Adult; Condylomata Acuminata; Female; Fluorouracil; Humans; Imiquimod; Male; Pain; Salicylic Acid; Treatment Outcome; Warts | 2022 |
A comparison of invasive squamous cell carcinoma greater than 1 year after treatment with 5-fluorouracil, imiquimod, or photodynamic therapy with aminolevulinic acid.
Topics: Aminolevulinic Acid; Carcinoma, Squamous Cell; Fluorouracil; Humans; Imiquimod; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2022 |
Meatal Intraurethral Warts Successfully Treated with 5-fluorouracil Cream.
Topics: Adult; Condylomata Acuminata; Fluorouracil; Humans; Imiquimod; Male; Papillomaviridae; Trichloroacetic Acid; Warts | 2022 |
Cutaneous T-Cell Lymphoma Treatment: Case Series of Combination Therapy With Intralesional Injections of 5-Fluorouracil and Topical Imiquimod.
Topics: Fluorouracil; Humans; Imiquimod; Injections, Intralesional; Lymphoma, T-Cell, Cutaneous; Skin Neoplasms | 2023 |
Keratinocyte Carcinoma Chemoprevention With a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.
Topics: Carcinoma, Squamous Cell; Chemoprevention; Fluorouracil; Humans; Imiquimod; Keratinocytes; Keratosis, Actinic; Prospective Studies; Treatment Outcome; Tretinoin | 2023 |
Feasibility of 5-fluorouracil and imiquimod for the topical treatment of cervical intraepithelial neoplasias (CIN) 2/3.
Topics: Adult; Feasibility Studies; Female; Fluorouracil; Humans; Imiquimod; Papillomaviridae; Papillomavirus Infections; Prospective Studies; Uterine Cervical Dysplasia; Uterine Cervical Neoplasms; Young Adult | 2023 |
[Current Management of Basal Cell Carcinoma].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Basal Cell; Cryotherapy; Fluorouracil; Humans; Imiquimod; Phototherapy; Radiotherapy; Skin Neoplasms | 2023 |